Lamotrigine Tablet, Extended Release
Product Images NDC 68382-982

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68382-982). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 01

Chemical structure diagram of the active ingredient Lamotrigine showing the arrangement of chlorine, nitrogen, and amino groups in the molecular structure.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 02

A cumulative response curve chart comparing Lamotrigine extended-release tablets with placebo. The X-axis shows the percent of patients, and the Y-axis indicates the percent improvement. Two lines represent the response rates for placebo and Lamotrigine over the patient population.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 03

A line graph comparing the percent of patients against the Percent Response Page Count of Seizure Improvement for Lamotrigine Extended-release tablets (N=116) and Placebo (N=121). The graph shows relative seizure improvement, with percentage improvement on the vertical axis and percent of patients on the horizontal axis.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 04

Lamotrigine 25 mg Extended-Release Tablets, USP label for oral use by Zydus Pharmaceuticals USA Inc. The label states 'Once A Day' dosing and includes the NDC 68382-979-06. The label shows a tan, round tablet imprinted with '979' and indicates a package size of 30 tablets, Rx only. Manufacturer is Zydus Lifesciences Ltd., Ahmedabad, India, and distributor is Zydus Pharmaceuticals (USA) Inc., Pennington, NJ.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 05

Label for Lamotrigine extended-release tablets, USP 50 mg by Zydus Pharmaceuticals USA Inc. The label indicates a 30-tablet bottle for oral use, includes a depiction of a round beige tablet marked '980,' and states this is a once-a-day prescription medication. It includes storage instructions, child-resistance warnings, and manufacturer details for Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 06

Lamotrigine Extended-Release Tablets, USP 100 mg oral tablets in a bottle label format. The label includes the NDC number 68382-981-06 and states "Once A Day" dosing. It features a visual of a round tan tablet imprinted with "981". The packaging contains 30 tablets, is Rx only, and is manufactured by Zydus Lifesciences Ltd., with distribution by Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 07

Label for Lamotrigine Extended-Release Tablets USP, 200 mg, oral dosage form by Zydus Pharmaceuticals USA Inc. The label indicates a 30-tablet package with child-resistant packaging, usage instructions, and distributor details. The NDC code is 68382-982-06, and safety and storage warnings including verifying product dispensing and keeping out of reach of children are present.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 08

Label for Lamotrigine Extended-Release Tablets USP 250 mg by Zydus Pharmaceuticals USA Inc. The label indicates a 30-tablet bottle with NDC 68382-983-06. The tablet image is gray and oval-shaped with imprint 983. The packaging states once-a-day dosing and includes storage instructions, child-resistant packaging note, and distributor information.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 09

Packaging label for Lamotrigine Extended-Release Tablets USP 300 mg by Zydus Pharmaceuticals USA Inc. The label indicates the product is oral extended-release tablets, with a package count of 30 tablets. It includes dosing caution, pharmacy dispensing instructions, child-resistant packaging notice, storage conditions, and manufacturer and distributor information. The label also features a barcode and a tablet imprint image.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 258 2

Lamotrigine extended release oral tablet with imprint '979'. The tablet is round, white, and scored. Manufactured by Zydus Pharmaceuticals USA Inc. Strength is not specified in the image.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 258 3

Lamotrigine 100 mg extended-release tablet, oval-shaped and light green, imprinted with '980'. This oral human prescription drug is labeled by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 258 4

Lamotrigine 100 mg extended release oral tablet, oval-shaped and light brown in color, with the imprint "981". Manufactured by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 258 5

Lamotrigine 25 mg extended release tablet, oval and white, imprinted with the code '982'. This oral dosage form is manufactured by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 258 6

Lamotrigine 50 mg extended-release oral tablet imprinted with '983'. The white, oval-shaped tablet is from Zydus Pharmaceuticals USA Inc.*

FDA Label Image

11b431ca E7f1 4ef2 B2d6 1be2294d09b2 258 7

Lamotrigine 100 mg extended-release oral tablet, light green, oblong-shaped with the imprint '984' on one side. Manufactured by Zydus Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.